Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics that power qPCR/RT-qPCR, Isothermal Amplification, and Next-Generation Sequencing (NGS) library preparation.
By integrating AI-driven design and high-throughput assays, Fapon actively leverages its AI-enabled enzyme engineering platform to improve product performance. Its showcased enzymes and reagents are engineered to enhance the accuracy, efficiency, and reliability of molecular testing. Featured products include:
- MeloScript Reverse Transcriptase offers superior target adaptability, exceptional inhibitor tolerance, high thermastability and high sensitivity.
- ProPrime Taq DNA Polymerase delivers ultra-fast amplification, exceptional resistance to inhibitors and superior sensitivity.
- PreciAmp Bst DNA Polymerase enables fast LAMP amplification with high speed, high sensitivity and strong inhibitor tolerance.
- NextGen Universal FS DNA Library Prep Kit facilitates uniform enzymatic fragmentation, enhanced genome coverage, broad sample compatibility, and fast, automation-friendly library construction.
During the meeting & expo, Dr. Nick Guan, Vice President of Molecular Diagnostics R&D at Fapon Biotech, will host a corporate workshop titled “Shaping the Future of Molecular Testing: Innovative Enzymes at the Core” on November 12, 2025. The session will explore how cutting-edge enzyme engineering drives next-generation PCR, NGS, and Isothermal Amplification technologies.
Fapon aims to provide industry-leading, high-quality molecular enzymes and reagents to empower customers with advanced molecular diagnostics. Additionally, Fapon has reinforced its commitment to the U.S. market with a dedicated Boston-based R&D center focused on enzyme innovation and a local warehouse for streamlined customer support.
Read Also: Gilead Provides Update on Phase 3 ASCENT-07 Study
